van Leeuwen, Anoek L. I.
Dekker, Nicole A. M.
Van Slyke, Paul
de Groot, Esther
Vervloet, Marc G.
Roelofs, Joris J. T. H.
van Meurs, Matijs
van den Brom, Charissa E. http://orcid.org/0000-0002-0886-1388
Funding for this research was provided by:
Hartstichting (2016T064)
CSL Behring Foundation for Research and Advancement of Patient Health (Prof Heimburger Award)
European Society of Anaesthesiology (Research project grant 2016)
European Society of Intensive Care Medicine (Levi-Montalcini Award 2017)
Dutch society of anesthesiology (Young Investigator Grant 2017)
Dutch Research Council (Veni 2019)
Article History
Received: 23 February 2021
Accepted: 21 April 2021
First Online: 17 May 2021
Declarations
:
: All procedures were approved by the Institutional Animal Care and Use Committee of the VU University, the Netherlands (Animal welfare number: ANES 13-03A2), and conducted following the European Convention for the Protection of Vertebrate Animals used for Experimental and Other Scientific Purposes and the ARRIVE guidelines on animal research.
: Not applicable.
: PVS is listed as inventor on multiple patents related to Vasculotide filed by Sunnybrook Health Sciences Centre and Vasomune Therapeutics, Canada. For the remaining authors none were declared.